Singapore Cancer Network (SCAN) Guidelines for Adjuvant Chemotherapy in Resected Non-Small Cell Lung Cancer

被引：0

作者：

Soo, Ross ^{[1
]}

Lim, Darren ^{[2
]}

Chang, Alex ^{[3
]}

Chew, Lita ^{[4
]}

Chin, Tan Min ^{[1
]}

Goh, Boon Cher ^{[1
]}

Leong, Swan Swan ^{[5
]}

Lim, Elaine ^{[6
]}

Lim, Hong Liang ^{[7
]}

Tan, Daniel ^{[2
]}

Tan, Tira ^{[2
]}

Toh, Chee Keong ^{[2
]}

Yeo, Wee Lee ^{[3
]}

机构：

[1] Natl Univ Canc Inst, Dept Haematol Oncol, Singapore 119228, Singapore

[2] Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore

[3] John Hopkins Singapore, Oncol, Singapore, Singapore

[4] Natl Canc Ctr Singapore, Dept Pharm, Singapore, Singapore

[5] OncoCare Canc Ctr, Singapore, Singapore

[6] Singapore Oncol Consultants, Singapore, Singapore

[7] Pkwy Canc Ctr, Singapore, Singapore

来源：

ANNALS ACADEMY OF MEDICINE SINGAPORE | 2015年 / 44卷 / 10期

关键词：

Decision-making; Postoperative therapy; VINORELBINE PLUS CISPLATIN; TRIALIST ASSOCIATION ANITA; INDIVIDUAL PATIENT DATA; POSTOPERATIVE RADIOTHERAPY; RANDOMIZED-TRIAL; STAGE-II; INSTITUTE; CANADA; JBR.10;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Introduction: The SCAN lung cancer workgroup aimed to develop Singapore Cancer Network (SCAN) clinical practice guidelines for the use of adjuvant systemic therapy for non-small cell lung cancer in Singapore. Materials and Methods: The workgroup utilised a modified ADAPTE process to calibrate high quality international evidence-based clinical practice guidelines to our local setting. Results: Five international guidelines were evaluated-those developed by the National Comprehensive Cancer Network (2014), European Society of Medical Oncology (2014), National Institute of Clinical Excellence (2012), Scottish Intercollegiate Guidelines Network (2014), and the Cancer Care Council Australia (2012). Recommendations on the selection of patients, chemotherapy regimen, treatment for stage I disease, treatment for positive margins and treatment options for pN2 disease with negative margins were produced. Conclusion: These adapted guidelines form the SCAN Guidelines 2015 for adjuvant systemic therapy of non-small cell lung cancer.

引用

页码：440 / 448

页数：9

共 50 条

[31] Impact of adjuvant chemotherapy in completely resected stage IIIA non-small cell lung cancer
Naim Younes, R.
Gross, J. L.
Abrao, F. C.
Rodrigues Pereira, J.
MINERVA CHIRURGICA, 2013, 68 (02) : 169 - 174
[32] Is there a role for adjuvant therapy for resected non-small cell lung cancer?
Jett, JR
THORAX, 1999, 54 : S37 - S41
[33] Adjuvant and neoadjuvant chemotherapy for non-small cell lung cancer
Livingston, RB
ANNALS OF ONCOLOGY, 1998, 9 : 4 - 4
[34] Adjuvant Chemotherapy Uptake in Non-small Cell Lung Cancer
Younis, Tallal
Al-Fayea, Turki
Virik, Kiran
Morzycki, Wojciech
Saint-Jacques, Nathalie
JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (11) : 1272 - 1278
[35] Adjuvant and induction chemotherapy in non-small cell lung cancer
Pirker, R
Malayeri, R
Huber, H
ANNALS OF ONCOLOGY, 1999, 10 : 71 - 76
[36] Adjuvant chemotherapy and radiotherapy in non-small cell lung cancer
Erman, M
Moretti, L
Soria, JC
Le Chevalier, T
Van Houtte, P
SEMINARS IN RADIATION ONCOLOGY, 2004, 14 (04) : 315 - 321
[37] The role of adjuvant chemotherapy for non-small cell lung cancer
Gurublihagavatula, S
Lynch, TJ
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 26 (03) : 298 - 303
[38] Adjuvant chemotherapy in the elderly with non-small cell lung cancer
Lee, Mijung
Wang, Dongliang
Pinto, Ian G.
Graziano, Stephen
Gajra, Ajeet
CANCER RESEARCH, 2014, 74 (19)
[39] Adjuvant chemotherapy in non-small cell lung cancer (NSCLC)
Felip, E.
Cedres, S.
Peralta, S.
Prat, A.
ANNALS OF ONCOLOGY, 2007, 18 : 143 - 146
[40] Adjuvant chemotherapy in completely resected non-small-cell lung cancer
Pisters, KMW
Le Chevalier, T
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (14) : 3270 - 3278

← 1 2 3 4 5 →